Your browser doesn't support javascript.
loading
Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients.
Kemp Bohan, Phillip M; Kirby, Derek T; Chick, Robert C; Bader, Julia O; Clifton, G Travis; Vreeland, Timothy J; Nelson, Daniel W.
Affiliation
  • Kemp Bohan PM; Department of Surgery, Brooke Army Medical Center, Houston, TX, USA.
  • Kirby DT; Department of Surgery, William Beaumont Army Medical Center, El Paso, TX, USA.
  • Chick RC; Department of Surgery, Brooke Army Medical Center, Houston, TX, USA.
  • Bader JO; Department of Clinical Investigation, William Beaumont Army Medical Center, El Paso, TX, USA.
  • Clifton GT; Department of Surgery, Brooke Army Medical Center, Houston, TX, USA.
  • Vreeland TJ; Department of Surgery, Brooke Army Medical Center, Houston, TX, USA.
  • Nelson DW; Department of Surgery, William Beaumont Army Medical Center, El Paso, TX, USA. usarmydoc@mac.com.
Ann Surg Oncol ; 28(3): 1466-1480, 2021 Mar.
Article in En | MEDLINE | ID: mdl-32749621
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gallbladder Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gallbladder Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States